MedTrace Logo

Home Monitoring to Predict Exacerbation in Cystic Fibrosis

NCT02416375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 147

Last updated 2021-03-16

No results posted yet for this study

Summary

The study aims to establish if it is possible for people with Cystic Fibrosis to monitor a number of parameters on a daily basis at home which might predict respiratory infections before they have symptoms and which might also predict treatment failures before this is obvious with conventional measures.

Conditions

Sponsors & Collaborators

  • Cystic Fibrosis Trust

    collaborator OTHER

  • King's College Hospital NHS Trust

    collaborator OTHER

  • Royal Brompton & Harefield

    collaborator UNKNOWN

  • The Leeds Teaching Hospitals NHS Trust

    collaborator OTHER

  • University Hospital Southampton NHS Foundation Trust

    collaborator OTHER

  • Microsoft Research

    collaborator INDUSTRY

  • Frimley Park Hospital NHS Trust

    collaborator OTHER

  • University Hospitals Bristol and Weston NHS Foundation Trust

    collaborator OTHER

  • Papworth Hospital NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Andres Floto, Prof · Papworth Hospital NHS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-01-31
Completion
2019-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02416375 on ClinicalTrials.gov